Back Jerne, NK (8 Dec 1984) 'The generative grammar of the immune system', Nobel Lecture.Back Jerne, NK, Henry, CH, Nordin, AA, et al (1974) 'Plaque forming cells: Methodology and theory', Transplant Review , 18, 130-191.Back Jerne, NK, Nordin, AA (1963) 'Plaque formation in agar by single antibody-producing cells', Science , 140, 405.Back Jerne, Nk, Nordin, AA, Henry, C (1963) 'The agar plaque technique for recognizing antibody-producing cells', in B Amons, H Koprowski, eds, Cell-Bound Antibodies , 109-25.Back Jerne, NK, Nordin, A, Henry, C, et al (10 Sept 1965) 'The agar plaque technique, the target of the antigen and clonal selection', Scientific Memo: Information Exchange Group No.5, in I Lefkovits (1996) ed, A Portrait of the Immune System, Scientific Publications of NK Jerne , 348-82.Back Lederberg, J (1988) 'Ontogeny of the clonal selection theory of antibody formation: Reflections on Darwin and Ehrlich', Annals of the New York Academy of Sciences , 546, 175-82.Back Lefkovits, I (1972) 'Induction of antibody-forming cell clones in microcultures', European Journal of Immunology , 2, 360-66.Back Lefkovits, I (1996) 'An Overview of the Lifework of Niels K Jerne', in I Lefkovits, ed, A Portrait of the Immune System, Scientific Publications of NK Jerne , 11-38
The RevIVe Wellness Approach At RevIVe Wellness, peptides like BPC-157 are approached with the same standards as any medical therapy: education, precision, and patient-first care
To reduce hematocrit, therapeutic phlebotomy (blood donation or removal) is often recommended
In a pool of two ZEPBOUND clinical trials for weight reduction (Studies 1 and 2), cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients
Nadeem, A
